EUVIMEDObjevte EUVIMED
EUVIMED · CrossrefJournal

Signal Transduction and Targeted Therapy

ISSN 2059-3635 · Springer Science and Business Media LLC

Latest articles

  1. Glycolipid-lectin driven endocytosis as a therapeutic vulnerability in breast cancer

    Amir Fardin, Andrea Francesco Benvenuto, Irene Schiano Lomoriello, Chiara Tordonato, Micaela Quarto, Stefano Freddi, Maria Chiara Rainone, Giovanni Giangreco, Giovanni Bertalot, Francesca Montani, Ivan Nicola Colaluca, Roberta Cacciatore, Andrea Raimondi, Maria Giovanna Jodice, Maria Grazia Malabarba, Luigi Scietti, Giuseppe Ciossani, Alessandro Cuomo, Massiullah Shafaq-Zadah, Estelle Dransart, Sina Kanannejad, Brenda Green, Salvatore Pece, Stefano Confalonieri, Ulf J. Nilsson, Hakon Leffler, Giorgio Scita, Ludger Johannes, Pier Paolo Di Fiore, Sara Sigismund

    Published: 2026-11-11DOI: 10.1038/s41392-026-03026-3

  2. MUC1 attenuates chronic obstructive pulmonary disease through integrated regulation of pulmonary epithelial cell senescence, transdifferentiation, and inflammatory cascades

    Zili Zhang, Defu Li, Weiguo Kong, Zeqiang Lin, Fei Liu, Fanjie Lin, Lulu Wu, Jiayu Zhuang, Lixia He, Wei He, Yuanyuan Li, Lingdan Chen, Xiaochang Wang, Yuhan Jiang, Yuanfang Xie, Qiaojian Zhong, Fang Tian, Ting Lu, Jingyi Xu, Ziyin Ye, Hongwei Yao, Tao Wang, Kwang Chul Kim, Zeguang Zheng, Dejun Sun, Jian Wang, Nanshan Zhong, Wenju Lu

    Published: 2026-11-09DOI: 10.1038/s41392-026-03056-x

  3. An actionable GPCR restores phosphoinositide homeostasis and kidney function in Lowe syndrome

    Leopoldo Staiano, Marialuisa Testa, Mariella Vicinanza, Francesca Cervellini, Laura Giaquinto, Lorenzo Patanella, Giuseppe Di Tullio, Michele Santoro, Annamaria Carissimo, Alessandro Giordano, Michele Genovese, Luis Juan Vicente Galietta, Anna Iervolino, Antonio Miele, Diego Luis Medina, Francesco Trepiccione, Francesco Emma, Olivier Devuyst, Robert Nussbaum, Maria Antonietta De Matteis

    Published: 2026-11-04DOI: 10.1038/s41392-026-03054-z

  4. Sitagliptin, a repurposed diabetes drug, overcomes gemcitabine resistance in pancreatic cancer via ribonucleotide reductase inhibition: SITGEM-CARE phase 2 trial

    Jun Yu, Shangheng Shi, Mengyu Li, Qingxiao Fang, Jingrui Yan, Yunfeng Zhang, Ziyun Liu, Zekun Li, Libo Wang, Zongjing Lv, Yadi Wang, Tao Wang, Zhen Zhao, Xiaoqing Ma, Jin Zhang, Guanpeng Xie, Huihui Sun, Ningning Zhao, Antao Chang, Yukuan Feng, Hongwei Wang, Xingyun Chen, Yuexiang Liang, Tiansuo Zhao, Jian Wang, Weidong Ma, Chuntao Gao, Song Gao, Bin Wang, Yongjie Xie, Tianxing Zhou, Chao Yang, Xiuchao Wang, Jihui Hao

    Published: 2026-11-03DOI: 10.1038/s41392-026-02966-0

  5. Neoadjuvant concurrent or sequential anthracycline-containing chemotherapy and HER2-targeted agents for HER2-positive breast cancer: a randomized phase 2 study (METIS)

    Qiufan Zheng, Shusen Wang, Zhiyong Wu, Muyi Zhong, Fei Xu, Shihui Ma, Yuanqi Zhang, Lehong Zhang, Yanxia Shi, Ying Wang, Heng Huang, Xiaopeng Ma, Xiangdong Xu, Haiyan Li, Jibin Li, Xiwen Bi, Jiajia Huang, Kuikui Jiang, Xin An, Ruoxi Hong, Meiting Chen, Cong Xue, Yongyi Zhong, Zhongyu Yuan, Wen Xia

    Published: 2026-11-02DOI: 10.1038/s41392-026-02834-x

Volumes

2026 · 5052025 · 4282024 · 3712023 · 4672022 · 4022021 · 4412020 · 2992019 · 642018 · 332017 · 382016 · 22

Znalosti, které odpovídají vaší práci.

Od bezplatného začátku přes osobní rešerše literatury až po kompletní Research Suite.

Zobrazit tarify →

Jsou zahrnuty všechny plné texty vydavatelů?

Ne. Bibliografické záznamy, abstrakty a plné texty jsou různé typy obsahu. To, zda je plný text dostupný, závisí na zdroji, Open Access a vašich stávajících licencích. Tarif EUVIMED nenahrazuje dodatečná vydavatelská práva.